default author photo

Michael T. Lewis

Baylor College of Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

15

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase 2 Neoadjuvant Study of Enzalutamide and Paclitaxel in the Treatment of LAR-Enriched TNBC: Trial Results and Insight Into ARness

Number of pages: 103 Posted: 28 Jun 2023
University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Genomic Medicine, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, Cold Spring Harbor Laboratory, University of Texas at Houston - Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, University of Texas at Houston - Biostatistics, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Baylor College of Medicine - Department of Surgery, University of Texas at Houston - Department of Breast Medical Oncology and University of Texas at Houston - Department of Breast Medical Oncology
Downloads 15 (1,500,778)

Abstract:

Loading...

Triple Negative Breast Cancer, Androgen receptor, Enzalutamide, ARness, Biomarker of response